US6185455B1
Expired / Lapsed
US
⏱️ 0.0 years remaining
Method of reducing the incidence of medical complications using implantable microstimulators
Assignee: Boston Scientific Neuromodulation Corp
•
Filing: 2000-01-25
•
Granted: 2001-02-06
•
Expires: 2020-01-25
Abstract
Abstract Improved implantable microstimulators are covered with a biocompatible polymeric coating in order to provide increased strength to the capsule and to capture fragments of the microstimulator should it become mechanically disrupted. Such coating also makes the microstimulator safer and easier to handle. The coating may include one or more diffusible chemical agents that are released in a controlled manner into the surrounding tissue. The chemical agents, such as trophic factors, antibiotics, hormones, neurotransmitters and other pharmaceutical substances, are selected to produce desired physiological effects, to aid, support or to supplement the effects of the electrical stimulation. Further, microstimulators in accordance with the invention provide systems that prevent and/or treat various disorders associated with prolonged inactivity, confinement or immobilization of one or more muscles. Such disorders include pressure ulcers, venous emboli, autonomic dysreflexia, sensorimotor spasticity and muscle atrophy. The microstimulator systems include external control for controlling the operation of the microstimulators. The control include memory for programming preferred stimulation patterns for later activation by the patient or caregiver.
Inventors
- 👤 Gerald E. Loeb
- 👤 Frances J. R. Richmond
Bibliographic Details
Application Number
—
Jurisdiction
US
Data Source
google_patents
Last Synchronized
2026-11-09 08:22
CPC Classifications
A; A61; A61N; A61N1/00; A61N1/18; A61N1/32; A61N1/36; A61N1/372; A61N1/375; A61N1/326; A61N1/36003; A61N1/3605; A61N1/37205; A61N1/37211; A61N1/37235; A61N1/3756
Claims Analysis
Total Claims: 5
Claim 1
Independent Claim
177 words
A method for reducing the incidence of medical complications from physical inactivity, confinement or immobilization of the whole body or parts thereof, comprising: (a) coating a substantial portion of the surface of at least one implantable microstimulator with a coating containing a pharmaceutical agent, wherein each of the at least one implantable microstimulator comprises a hermetically-sealed housing, at least two exposed electrodes, and electronic means within said hermetically-sealed housing for generating an electrical current and applying said electrical current to said at least two exposed electrodes; (b) implanting the at least one implantable microstimulator in muscle associated with an affected site; (c) administering prescribed sequences of electrical stimulation through the at least two exposed electrodes of the at least one implantable microstimulator to nerves or muscles in the vicinity of the at least one implantable microstimulator; and (d) controlling the at least one implantable microstimulator to electrically excite a physiological response from the body tissue near the at least two exposed electrodes simultaneously with elution of a locally high level of the pharmaceutical agent from the coating.
Claim 2
Independent Claim
177 words
A method for reducing the incidence of medical complications from physical inactivity, confinement or immobilization of the whole body or parts thereof, comprising: (a) coating a substantial portion of the surface of at least one implantable microstimulator with a coating containing a pharmaceutical agent, wherein each of the at least one implantable microstimulator comprises a hermetically-sealed housing, at least two exposed electrodes, and electronic means within said hermetically-sealed housing for generating an electrical current and applying said electrical current to said at least two exposed electrodes; (b) implanting the at least one implantable microstimulator in muscle associated with an affected site; (c) administering prescribed sequences of electrical stimulation through the at least two exposed electrodes of the at least one implantable microstimulator to nerves or muscles in the vicinity of the at least one implantable microstimulator; and (d) controlling the at least one implantable microstimulator to electrically excite a physiological response from the body tissue near the at least two exposed electrodes simultaneously with elution of a locally high level of the pharmaceutical agent from the coating.
Claim 3
Dependent Claim
53 words
The method of claim 1 wherein the step of coating includes applying said coating so that said coating contacts at least one of said at least two exposed electrodes, whereby electrical current/voltage applied to said at least two exposed electrodes affects the rate at which the pharmaceutical agent is eluted from the coating.
Claim 4
Independent Claim
158 words
A method for reducing the incidence of medical complications resulting from physical inactivity, confinement or immobilization of the whole body or parts thereof, comprising: (a) implanting at least one implantable microstimulator in muscle associated with an affected site, wherein each of the at least one implantable microstimulator comprises a hermetically-sealed housing, a battery for providing operating power to the at least one implantable microstimulator, at least two exposed electrodes, and electronic means within said hermetically-sealed housing for generating an electrical current and applying said electrical current to said at least two exposed electrodes; and (b) administering prescribed sequences of electrical stimulation through the at least two exposed electrodes of the at least one implantable microstimulator to nerves or muscles in the vicinity of the at least one implantable microstimulator comprising: preprogramming the at least one implantable microstimulator with a desired sequence and pattern of electrical stimulation; and activating said sequence and pattern of electrical stimulation at prescribed intervals.
Claim 5
Independent Claim
158 words
A method for reducing the incidence of medical complications resulting from physical inactivity, confinement or immobilization of the whole body or parts thereof, comprising: (a) implanting at least one implantable microstimulator in muscle associated with an affected site, wherein each of the at least one implantable microstimulator comprises a hermetically-sealed housing, a battery for providing operating power to the at least one implantable microstimulator, at least two exposed electrodes, and electronic means within said hermetically-sealed housing for generating an electrical current and applying said electrical current to said at least two exposed electrodes; and (b) administering prescribed sequences of electrical stimulation through the at least two exposed electrodes of the at least one implantable microstimulator to nerves or muscles in the vicinity of the at least one implantable microstimulator comprising: preprogramming the at least one implantable microstimulator with a desired sequence and pattern of electrical stimulation; and activating said sequence and pattern of electrical stimulation at prescribed intervals.
References Cited (Backward Citations)
FR2107826A1
Cited
US4026304A
Cited
US3971388A
Cited
US4041955A
Cited
EP0047013A1
Cited
US4524774A
Cited
US5167229A
Cited
US5094242A
Cited
US4991582A
Cited
WO1992000747A1
Cited
US5482008A
Cited
US5312439A
Cited
US5193540A
Cited
US5193539A
Cited
US5324316A
Cited
US5405367A
Cited
WO1994005361A1
Cited
WO1997029802A2
Cited
US5814089A
Cited
USPTO Annuity & Maintenance Windows
| Annuity Stage | Window Opens | Payment Deadline | Surcharge Period Until | Estimated Fee | Status |
|---|---|---|---|---|---|
| 3.5 Years (Year 4) | 2004-02-06 | 2004-08-07 | 2005-02-06 | $2000.00 | Window Closed / Lapsed |
| 7.5 Years (Year 8) | 2008-02-06 | 2008-08-07 | 2009-02-06 | $3760.00 | Window Closed / Lapsed |
| 11.5 Years (Year 12) | 2012-02-06 | 2012-08-07 | 2013-02-06 | $7700.00 | Window Closed / Lapsed |